Thyroid carcinoma in patients with secondary hyperparathyroidism

Area of Science:

• Endocrinology
• Oncology
• Surgical Pathology

Background:

• Secondary hyperparathyroidism (2° HPT) is a condition with limited reported associations with thyroid carcinoma.
• Thyroid nodules are common in patients with 2° HPT.

Purpose of the Study:

• To investigate the incidence of thyroid carcinoma in patients with 2° HPT undergoing parathyroidectomy.
• To determine if there is a correlation between thyroid carcinoma and parathyroid hormone levels in this patient group.

Main Methods:

• Retrospective analysis of eleven consecutive patients with 2° HPT who underwent parathyroidectomy.
• Evaluation of associated thyroid nodules for malignancy (papillary carcinoma, follicular adenoma).
• Comparison of thyroid carcinoma incidence with a local autopsy cohort and analysis of carboxyl-terminal parathyroid hormone levels.

Main Results:

• Seven of eleven (64%) patients with 2° HPT had associated thyroid nodules.
• Three patients (36%) were diagnosed with thyroid carcinoma (papillary, follicular).
• The incidence of thyroid carcinoma in the 2° HPT group (36%) was significantly higher than the autopsy group (11%).
• Higher carboxyl-terminal parathyroid hormone levels were observed in patients with thyroid carcinoma compared to those without (P < 0.05).

Conclusions:

• There is a significantly higher incidence of thyroid carcinoma in patients with secondary hyperparathyroidism.
• Routine screening for thyroid cancer is recommended in patients diagnosed with secondary hyperparathyroidism.
• Elevated parathyroid hormone levels may be associated with the presence of thyroid carcinoma in these patients.